← Leaderboards
Adam D Cohen
Sloan-Kettering Inst Can Research
$276,486
Attributed
$276,486
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $138.2K · FY2007–08$200K$150K$100K$50K$0
'07
'08
Funding mix
By agency
NIH$276,486 · 1
By mechanism
K08$276,486 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Timothy An-Thy Chan$21,076,830
- Tobias M Hohl$16,351,909
- Tomas Kirchhoff$7,026,619
- Andrew Y Koh$4,547,928
- Jedd D. Wolchok$10,212,450
Others in their field
Top investigators on “Advanced Malignant Neoplasm”
- David Heimbrook · Leidos Biomedical Research, Inc.$417,129,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$354,493,986
- Walter John Curran · Thomas Jefferson University$125,181,729
- Peter J O'Dwyer · University Of Pennsylvania$123,221,383
- Philip J Disaia · University Of California Irvine$108,550,481
- Daniel R Kuritzkes · Brigham And Women'S Hospital$105,030,441
Research focus
Advanced Malignant NeoplasmAgonistAnimal ModelAntibodiesAntibodies, BlockingAntigensAutoantigensAutoimmunityCancer ImmunotherapyCancer PatientCancer VaccinesCd4 Positive T LymphocytesCd8b1 GeneCell PhysiologyCellsClinicClinically RelevantDesignEquilibriumFamily MemberGlucocorticoidsHypopigmentationImmuneActive Immunization